Save the Date!

11th Annual AACI CRI Meeting

July 9-11, 2019
Chicago, IL

View the CRI Call for Abstracts.

Learn More

Register Today!

AACI/AACR
Hill Day

April 30, 2019
Washington, DC

New this year: apply for a Hill Day Scholarship to bring a patient advocate to Washington! 

Learn More

Save the Date!

2019 AACI/CCAF Annual Meeting

October 20-22, 2019
Washington, DC

Learn More

A Year in Review

AACI 2018 Report

2018 was a year of transitions for AACI—a new president and executive director, fresh initiatives, and an expanded staff to better serve AACI’s 98 cancer center members.

Read the Report

In the News

NEXT Up with Jennifer Pegher

"It’s a truly exciting time for AACI and the cancer community at large."

Read More at NEXTpittsburgh

Latest News

AACI Update 
Read the February 2019 issue

11th Annual AACI CRI Meeting
View the Call for Abstracts

AACI/AACR Hill Day
Learn about our new Hill Day Scholarship 

CAR T Initiative in the News
Read the story in HemOnc Today

Our Mission

Working Together to Find a Cure

The Association of American Cancer Institutes (AACI) comprises 98 premier academic and freestanding cancer research centers in the U.S. and Canada. AACI is dedicated to reducing the burden of cancer by enhancing the impact of North America's leading academic cancer centers.

CRI

Clinical
Research

Acting as a network for research leaders, AACI's Clinical Research Innovation (CRI) examines and shares best practices that promote the efficient operation of clinical research facilities.

Discover CRI
Public Policy

Public
Policy

The AACI Government Relations Forum facilitates an improved understanding of policy issues as they pertain to cancer prevention, treatment, and survivorship – for AACI members and for legislators.

Take Action
Meetings & Events

Meetings & Events

AACI events bring together cancer center leadership with national cancer research and advocacy groups, industry, and government health agencies. AACI also shares event announcements as a benefit to members. 
View All Events

Recent Headlines

AACI Welcomes ASTRO as New Sustaining Member

AACI Welcomes ASTRO as New Sustaining Member

Read More
Join Us for the 2019 AACI/AACR Hill Day

Join Us for the 2019 AACI/AACR Hill Day

Read More

Meet the President

Roy A. Jensen, MD, has been the director of The University of Kansas Cancer Center since 2004. That year, he was also appointed the William R. Jewell, M.D. Distinguished Kansas Masonic Professor, the director of the Kansas Masonic Research Institute, professor of pathology and laboratory medicine, and professor of anatomy and cell biology at the University of Kansas Medical Center. Under his leadership, KU Cancer Center earned designation as a National Cancer Institute cancer center in 2012.

With over 150 scientific publications, Dr. Jensen has lectured widely on the clinical and molecular aspects of breast cancer pathology. His research focuses on understanding the function of BRCA1 and BRCA2 and their role in breast and ovarian neoplasia; and on the characterization of premalignant breast disease.

A member of AACI's board of directors since 2013, Dr. Jensen chaired the association's 2013 program committee.

AACI Board of Directors

Presidential Initiative

For over four decades, cancer centers have worked together to lower cancer incidence and mortality rates through research and sound public policy. Such efforts can save hundreds—if not thousands—of lives over many years and represent a critical tool for lowering cancer mortality.

AACI has an unprecedented opportunity to exert enormous influence on public policy, leveraging the collective efforts of its 98 cancer centers across North America for maximum impact.

For his presidential initiative, Dr. Roy Jensen will spearhead the development of a comprehensive, cancer-specific library of model legislation and other resources that are thoroughly vetted and customizable. 

Inspired by successful efforts at KU Cancer Center and the work of national cancer advocacy organizations, Dr. Jensen plans to launch the web-based library in 2019 to address issues ranging from oral chemotherapy parity and state funding for cancer research to HPV vaccination, tobacco regulation, and coverage of routine care for clinical trials.
 

Learn More